Metraipolis › archive › dc_e2045d361fc5

Implementation of guideline-recommended organ-protective therapy in people with type 2 diabetes and cardiovascular disease, heart failure, or kidney disease:… — Europe PMC PMID:41567800

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41567800
DOI
10.3389/fendo.2025.1736984
License (as archived)
solo-consultazione
Archived
2026-11-07T01:14:26.261Z
SHA-256 of the archived text
f6d29b13ef04f0a19807d6f57e6e43b57c69a4d415693e2155014249f5b2a83e
Stable URL of this page
https://metraipolis.com/documento/dc_e2045d361fc5

How to cite

Implementation of guideline-recommended organ-protective therapy in people with type 2 diabetes and cardiovascular disease, heart failure, or kidney disease:… — Europe PMC PMID:41567800 — Europe PMC (en), https://europepmc.org/article/MED/41567800 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e2045d361fc5 (Metraipolis archive dc_e2045d361fc5, sha256 f6d29b13ef04f0a19807d6f57e6e43b57c69a4d415693e2155014249f5b2a83e)
BibTeX
@misc{dce2045d361fc5,
  title = {Implementation of guideline-recommended organ-protective therapy in people with type 2 diabetes and cardiovascular disease, heart failure, or kidney disease:… — Europe PMC PMID:41567800},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41567800},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e2045d361fc5; sha256 f6d29b13ef04f0a19807d6f57e6e43b57c69a4d415693e2155014249f5b2a83e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41567800. Agents can read the archived copy with the MCP tool read_document.